Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial)

NCT04344041 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT04344041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04344041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial)
Lead sponsor
University Hospital, Angers
Phase
Phase 3
Overall status
Completed
Start date
April 15, 2020
Completion date
January 14, 2021
Enrollment
260 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus